Chemotherapy vs. Placebo
Links shared publicly online about this topic.
- 1,155total visits
Chemotherapy vs. Placebo
organiclifestylemagazine.com —
View full resource at organiclifestylemagazine.com
Tags: Cancer, Chemotherapy
Most Recently Shared on May 20, 2010 at 11:02 am By:
Chemotherapy vs. Placebo http://bit.ly/c829et #cancer
My 2 Cents: Estrogen vs Breast Cancer in Postmenopausal Hysterectomized Women
alvinblin.blogspot.com — “Thoughts on current medical literature & news as it pertains to optimizing our health.” View full resource at alvinblin.blogspot.com
Most Recently Shared on March 26, 2012 at 8:18 am By:
Alvin B. Lin Family Medicine Doctor, Geriatrician, Physician, and Doctor
New analysis of WHI shows #estrogen alone actually lowers risk of #breastcancer #cancer #death compared to placebo. http://t.co/W3QoSoPM
Study shows how to defeat chemotherapy barrier in pancreatic cancer
news-medical.net — “Scientists at Fred Hutchinson Cancer Research Center and the Translational Genomics Research Institute (TGen) have discovered a literal 'break through' in pancreatic cancer.” View full resource at news-medical.net
Most Recently Shared on March 21, 2012 at 9:21 am By:
Study shows how to defeat chemotherapy barrier in pancreatic cancer: Scientists at Fred Hutchinson Cancer Resear... http://t.co/ZyHSQxSw
FDA staff question benefit of Merck-Ariad drug - Yahoo! News
news.yahoo.com — “From Yahoo! News: WASHINGTON (Reuters) - U.S. drug reviewers questioned whether a sarcoma treatment from Merck & Co Inc and Ariad Pharmaceuticals Inc kept tumors at bay for long enough, given the drug's serious side effects. The drug, called Taltorvic, is meant as a maintenance therapy for people with soft tissue or bone sarcoma who have had four successful rounds of chemotherapy. U.S. Food and Drug Administration staff found the drug stopped cancer from spreading two weeks longer than a placebo” View full resource at news.yahoo.com
Most Recently Shared on March 16, 2012 at 4:19 pm By:
FDA staff question benefit of Merck-Ariad drug: WASHINGTON (Reuters) - U.S. drug reviewers questioned whether a ... http://t.co/ctXdTin7
What is the difference in treatment between an ovarian cancer caught in the early stage vs later stage? Does any stage involve chemotherapy treatments?
talkabouthealth.com — “The majority of cases of ovarian cancer (approximately 75%) are diagnosed at stage III or IV (spread of cancer outside the ovaries and into the abdominal cavity” View full resource at talkabouthealth.com
Most Recently Shared on February 23, 2012 at 7:51 pm By:
What is difference treating #ovariancancer early vs later stg? Does any stg involve chemo? TY @DrMarkham http://t.co/stEhjZz3 #cancer #bcsm
Pfizer Recalls 1M Birth Control Packs After Mixup - ABC News
abcnews.go.com — “Birth Control Pills Recalled After Mixup” View full resource at abcnews.go.com
Most Recently Shared on February 1, 2012 at 2:16 pm By:
do you take #birthcontrol pills? huge recall announcement came out yesterday: http://t.co/8qDyUH7n
New Research on the Antidepressant-vs.-Placebo Debate | Healthland | TIME.com
healthland.time.com — “In the 1990s, everyone was “Listening to Prozac,” after best-selling author Peter Kramer described sparkling personality transformations in patients who took the titular antidepressant drug.” View full resource at healthland.time.com
Most Recently Shared on January 19, 2012 at 2:45 pm By:
Do antidepressants work or don't they? | http://t.co/zpK4JZBc
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study : The Lancet
thelancet.com — “Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 stud...” View full resource at thelancet.com
Most Recently Shared on November 25, 2011 at 2:11 pm By:
More intensive chemotherapy dramatically improves recurrence and survival in younger patients with aggressive lymphoma http://t.co/CrJwbMs7
Low-Dose Rivaroxaban Looks Good in ACS: ATLAS ACS 2 - QualityPoint Technologies
qualitypointtech.net — “The lower of the two doses tested in the trial has shown promising results, with a reduction in overall and cardiovascular mortality vs placebo, despite an increased risk of bleeding and intracranial hemorrhage. But is this applicable to all patients? Heartwire” View full resource at qualitypointtech.net
Most Recently Shared on November 13, 2011 at 4:00 pm By:
Low-Dose Rivaroxaban Looks Good in ACS: ATLAS ACS 2: The lower of the two doses tested in the trial has shown prom... http://t.co/XYXiSSAe
Vapocoolant Spray vs Lidocaine/Prilocaine Cream for Reducing the Pain of Venipuncture in Hemodialysis Patients: A Randomized, Placebo-Controlled, Crossover Study
medsci.org — “Vapocoolant Spray vs Lidocaine/Prilocaine Cream for Reducing the Pain of Venipuncture in Hemodialysis Patients: A Randomized, Placebo-Controlled, Crossover Study” View full resource at medsci.org
Most Recently Shared on October 28, 2011 at 4:26 pm By:
Norman Marcus, M.D. Doctor, Pain Medicine Physician, and Physician
Ethyl Chloride spray as effective as EMLA for venipuncture pain in a small study of hemodialysis patients. http://t.co/kkeS5IQ4
GRACE :: Lung Cancer» Blog Archive » Afatinib vs. Placebo in EGFR-TKI Treated Patients: Efficacy in the Eye of the Beholder
cancergrace.org — “GRACE :: Lung Cancer» Blog Archive » Afatinib vs. Placebo in EGFR-TKI Treated Patients: Efficacy in the Eye of the Beholder” View full resource at cancergrace.org
Most Recently Shared on October 23, 2011 at 10:22 pm By:
Denise Brock - GRACE Health Organization
New article: Afatinib vs. Placebo in EGFR-TKI Treated Patients: Efficacy in the Eye of the Beholder http://t.co/vU1OJszW
Old Treatment May Offer New Hope for Smoking Cessation - QualityPoint Technologies
qualitypointtech.net — “A new randomized, controlled trial of more than 700 patients from Poland suggests that cytisine is effective as an aid in smoking cessation compared with placebo. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on September 28, 2011 at 11:45 pm By:
Old Treatment May Offer New Hope for Smoking Cessation: A new randomized, controlled trial of more than 700 patien... http://t.co/0U0gVsMq
Science-Based Medicine » Dummy Medicine, Dummy Doctors, and a Dummy Degree, Part 2.1: Harvard Medical School and the Curious Case of Ted Kaptchuk, OMD (cont.)
sciencebasedmedicine.org — “Rave Reviews In 1983, Ted Kaptchuk, the senior author of the recent 'albuterol vs. placebo' article, and soon to become the long-time Second-in-Command of the...” View full resource at sciencebasedmedicine.org
Most Recently Shared on September 16, 2011 at 11:30 am By:
David Gorski Surgeon, Oncologist, Physician, and Doctor
Dummy Medicine, Dummy Doctors, and a Dummy Degree, Part 2.1: Harvard Medical School and the Curious Case of Ted ... http://t.co/IikG2Jtk
Family Medicine Article | Nutrition
mdlinx.com — “Randomised clinical trial: the synbiotic food supplement Probiotical vs. placebo for acute gastroenteritis in children” View full resource at mdlinx.com
Most Recently Shared on September 11, 2011 at 8:16 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Randomised clinical trial: the synbiotic food supplement Probiotical vs. placebo for acute gastroen... http://t.co/tMCf6jh #FamPractice
Tarceva (erlotinib) Good Alternative To Chemotherapy For Some Lung Cancer Patients, UK
medicalnewstoday.com — “According to today's announcement by Roche, Tarceva (erlotinib), an oral lung cancer treatment, has been officially licensed as first-line monotherapy for the treatment of patients with advanced” View full resource at medicalnewstoday.com
Most Recently Shared on September 11, 2011 at 4:43 am By:
MedicalNewsToday: Tarceva (erlotinib) Good Alternative To Chemotherapy For Some Lung Cancer: http://t.co/sv66ODD Full http://t.co/NqqVsQf
JNCI: Concurrent chemo, radiotherapy for lung cancer boosts survival
healthimaging.com — “Treating some lung cancer patients with concurrent chemotherapy and radiation therapy significantly increased five-year survival rates vs. waiting to treat patients with radiation therapy after completing chemotherapy, according to a study published Sept. 8 in the Journal of the National Cancer Institute.” View full resource at healthimaging.com
Most Recently Shared on September 9, 2011 at 3:33 pm By:
Health Imaging & IT Health Magazine
JNCI: Concurrent chemo, radiotherapy for lung cancer boosts survival http://t.co/rhx8Xgd
Advertisement
